• Trusted resource for high-quality, cost-effective NIJ-certified body armor
• Serving U.S. government and law enforcement agencies for over 20 years
• Supplied ordnance to U.S. forces in Iraq and Afghanistan

Since 1997, HighCom Global Security, Inc. (OTC: HCGS) has been supplying the U.S. government and law enforcement agencies throughout the nation with a variety of soft and hard body protecting solutions. When U.S. troops were deployed in Iraq and Afghanistan, the company was there, playing a major role supplying hundreds of thousands of hard armor pieces. As a result, HighCom is now recognized as a trusted and valuable resource for high quality and cost-effective NIJ-certified armor solutions. Located in Columbus, Ohio, the company’s manufacturing and distribution facility and its R&D and ballistic laboratory allows it to effectively manage all critical aspects of design, production and supply of its products. And HighCom continues to work with the largest manufacturers and distributors in the world through its OEM and private-label program, many of whom rely on HighCom to design, develop, test and manufacture armor solutions under subcontract agreements.

Protecting law enforcement officers (LEOs) with effective body armor has become ever more crucial in recent times. Data published by the National Law Enforcement Officers Memorial Fund (NLEOMF) indicate the rising level of threat to LEOs. In 2016, law enforcement fatalities nationwide rose to their highest level in five years, with 135 officers killed in the line of duty (http://dtn.fm/72Tsn). This represents a 10 percent increase over the 123 who died in the line of duty in 2015 and is the highest total since 2011, when 177 officers made the ultimate sacrifice. Firearms-related incidents were the number one cause of death in 2016, with 64 officers shot and killed across the country. This represents a significant spike—56 percent—over the 41 officers killed by gunfire in 2015. Of the 64 shooting deaths of officers in 2016, 21 (33%) were the result of ambush-style attacks—the highest total in more than two decades. If nothing else, these alarming statistics demonstrate the pressing need LEOs have for effective body armor.

And HighCom, in the business of saving lives, has a wide range of body protection gear. Its product lineup includes Type IIA body armor, which offers basic protection against smaller caliber handgun threats; Type II body armor, which provides protection against larger handguns, including many common smaller caliber pistols with standard pressure ammunition and against many revolvers; Type IIIA body armor, which can resist heavy pistol calibers including most law enforcement ammunition and many higher powered revolvers, and Type III and IV body armor, which provide protection against rifle rounds, generally only used in tactical situations.

In February 2017, the company introduced four new hard armor models to its ballistic product line, receiving NIJ compliance status through the National Institute of Justice Compliance Testing Program (NIJ CTP), the only nationally accepted standard for body armor. And in July 2017, approval was received from the NIJ on two additional armor models: a Level IIIa elite, lightweight, high-performance soft armor panel; and a Level III++, multi-curve, hard armor ballistic plate. With the launch of these new models, HighCom Armor now has 11 hard armor NIJ 0101.06 certified ballistic plate models, as well as five soft armor NIJ 0101.06 certified panel solutions.

Operating from a 32,865 square foot manufacturing and distribution facility located in Columbus, Ohio, HighCom can handle large scale, time-sensitive global supply needs. Its logistics center in Florida serves customers in North America, such as the Department of Defense and the Department of Homeland Security, local law enforcement agencies, correctional facilities, municipal authorities and large corporations, as well as others throughout the world. Past sales have been to Asia, Africa, Europe, Latin America, and the Middle East. Recent financial performance has exceeded expectations. Revenues for the second quarter 2017 were $1.5 million, a triple-digit increase over revenues of $698K reported in the second quarter of 2016. For the first six months of 2017, HighCom Global reported revenues of $2.6 million, an increase of more than $700,000 from revenues of $1.9 million reported in the first half of 2016.

For more information about the company, visit its website at www.HighComGlobal.com

Let us hear your thoughts: HighCom Global Security, Inc. Message Board

• Skinvisible Pharmaceuticals, Inc. is making confident steps toward the large-scale distribution of its hand sanitizer in China
• Clinical studies show that frequent hand sanitization is the only effective non-pharmaceutical measure for influenza prevention
• Worries about the spread of avian influenza and its high mortality rate have triggered the introduction of more rigorous prophylactic measures and market growth

H7N9 (a type of avian influenza virus) could be the one to cause the next global flu pandemic, the World Health Organization (WHO) warns (http://dtn.fm/Nby8B). Luckily, the flu prophylactic market is already offering some adequate options, and DermSafe® by Skinvisible, Inc. (OTCQB: SKVI) subsidiary Skinvisible Pharmaceuticals, Inc. is one of them. In June, Skinvisible announced the first international sale of DermSafe in China – a country that’s known to have the first reported cases of human avian influenza infections.

As winter approaches, researchers warn that the risk of flu viruses spreading increases. H7N9 infections have been sporadic so far, but the virus has been mutating (http://dtn.fm/KqE8y). This would be its sixth year of existence, and, over this period of time, avian influenza has had a mortality rate of 36 percent among 1,562 lab-confirmed infections. The fifth wave of the viral infection (starting in 2017) has been the deadliest one yet. Out of 764 infected individuals, 250 died because of the virus.

Virus mutations, more serious epidemics and their consequences are making researchers work hard on the creation of flu prevention products. Influenza vaccines are becoming more popular than ever before, with a projected growth in the U.S. from 147.8 million doses in 2016 to 179 million doses in 2017 (http://dtn.fm/9pFYj). The current value of the market is estimated at $4 billion.

Apart from vaccination, the use of the right personal hygiene products is another highly effective way to prevent the spread of flu viruses, including H7N9. According to a report presented in the BMC Public Health Journal, frequent hand washing and sanitization (at least five times per day) is the only non-pharmaceutical prophylactic measure that is a statistically-significant protective factor in the case of pediatric influenza (http://dtn.fm/h6J06).

Hand sanitizers like Skinvisible’s DermSafe could be one of the answers when it comes to influenza prevention. Independent studies of the product suggest that DermSafe kills germs immediately upon application, and it also provides four additional hours of protection upon topical use. In addition to its powerful anti-bacterial/viral properties, DermSafe is free from alcohol. This means that it doesn’t have a drying effect, and it feels pleasant on the skin.

DermSafe’s formulation features chlorhexidine gluconate in a four-percent concentration. This ingredient has proven its ability to kill both gram-positive and gram-negative bacteria, as well as viruses. It also offers long-lasting protection from germs when human skin comes in contact with hard surfaces. Through clinical tests, it’s been proven that the active ingredient in DermSafe is effective against H7N9, as well as H1N1 – the swine flu virus.

Since DermSafe is approved for sale by Health Canada, prior to its product launch in China, DermSafe was used by the Canadian Olympic team during the games in Rio. The Olympic team was capable of successfully addressing concerns stemming from water quality through the use of the hand sanitizer. The Canadian Olympic team will also be protected by DermSafe in February 2018 at the Winter Olympic Games in South Korea.

Skinvisible Pharmaceuticals is looking for opportunities to expand the distribution of DermSafe globally. In 2013, the Company obtained registration rights for DermSafe in Belgium. Through this designation, the hand sanitizer can be registered and distributed in most EU countries. The larger long-term strategy includes the effective distribution of the company’s product globally.

For more information, visit the company’s website at www.Skinvisible.com

Let us hear your thoughts: Skinvisible, Inc. Message Board

• World demand for lithium expected to increase 300% by 2025
• Global lithium compounds market projected to reach U.S. $5.87 billion by 2020
• Electric vehicles are on track to take 54% of new car sales by 2040
• Exploration of Bristol Lake Project reveals excellent lithium-bearing brine harvest potential

Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF), a Canadian energy exploration and development company, is aggressively working to fill the increasing demand for lithium as it focuses on its Bristol Dry lake lithium brine project located in California’s Mojave Desert. As a junior mining company, Standard Lithium is building one of the largest portfolios of high quality, domestic U.S. lithium brine assets.

Bloomberg New Finance reports the global long-term outlook for electric vehicles is moving faster than the firm predicted a year ago. EVs are on track to accelerate to 54 percent of new car sales by 2040 as more countries around the world seek alternatives to the internal combustion engine and the resulting pollution they cause (http://dtn.fm/bWCd7). In fact, the dynamics at play for lithium growth run the gamut as the future of transportation and energy efficiency accelerate the need for more of the world’s lightest metal.

Standard Lithium’s geophysics team recently concluded a comprehensive gravity survey over the company’s entire Bristol Dry Lake Lithium Project containing 35,000 acres of placer mineral claims and private property. Initial interpretation of the data indicate that high concentrations of lithium-bearing brines are present throughout the company’s mineral lease agreement claims (http://dtn.fm/EoFK0).

Key to the project’s success is the area’s excellent mining infrastructure that tackles the primary challenges facing lithium mining – access and cost-effective production. Through a strategic partnership with two permitted brine operators, National Chloride Corporation of America (NCAA) & TETRA Technologies (TETRA) , Standard Lithium has immediate access to conduct exploration brine sampling, evaporation and lithium processing activities, enabling a fast-track project development schedule.

In addition to the Bristol Lake Brine Project, Standard Lithium has signed a Letter of Intent with a NYSE-listed chemical processing company for 30,000-plus acres of brine leases in the Smackover Formation within southern Arkansas. This brine resource may be one of the lithium industry’s most promising projects to develop (http://dtn.fm/KY3Un), STLHF management believes. As world demand for lithium continues to grow, so does Standard Lithium’s determination to be a major player in the lithium compounds market.

For more information about the company, visit http://nnw.fm/standardlithium

• Clinical-grade salve is designed for topical skin use and contains full spectrum hemp oil, menthol, and essential oils; it is developed to treat minor skin irritations and tight or sore muscles
• Eqova will distribute salve to patients through licensed health practitioners
• Marijuana Business Conference (MJBizCon) is the industry’s premier and largest trade show, generating for Eqova an audience of potentially thousands of cannabis-related executives

Grey Cloak Tech, Inc. (OTCQB: GRCK), through subsidiary Eqova Life Sciences, will introduce CannaBio Salve at the Marijuana Business Conference (MJBizCon), to be held November 14-17 in Las Vegas (http://dtn.fm/3NbQb). Per the announcement, it is the industry’s premier cannabis trade show. CannaBio Salve is a topical skin product containing full spectrum hemp oil, menthol and essential oils.

The salve is designed to treat minor skin irritations and tight or sore muscles. It is Eqova’s second product developed for topical skin use.

GRCK acquired 100% of Eqova in an all-stock transaction last month. Eqova offers clinical-grade products manufactured in cGMP-compliant labs located in the United States. It is focused on the medical practitioner market, offering products that are carefully researched and tested by third-parties before and after marketing. These products use full-spectrum hemp oil plus other ingredients to achieve standardized dosing. Distribution to patients is achieved through licensed health practitioners, as noted on Eqova’s website.

In today’s news release, Matthew Grabau, Eqova Life Sciences co-founder and CMO, said, “We’re very excited about introducing CannaBio Salve. There has been a lot of interest from our practitioners in the product already. We’ve been taking pre-sales for the product for quite some time, and we fully expect it to be one of top two sellers.”

Eqova’s management team will be at MJBizCon in Las Vegas to introduce CannaBio Salve, as well as the rest of the company’s line. At this trade show, Eqova’s products will be seen by potentially thousands of cannabis-related executives.

For more information, visit the company’s website at www.GreyCloakTech.com

Let us hear your thoughts: Grey Cloak Tech, Inc. Message Board

• High-margin licensing royalties of 5-10% of gross sales of its patented bioscience technology and process are an attractive valuation builder; LXRP sees more licensing opportunities in 2018
• LXRP’s technology is patented in the U.S. and Australia; company has national/regional filings pending in 44 countries

Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) generates revenue by out-licensing its patented global technology related to ingestion of edible cannabinoids at a rate of 5-10% of gross sales to its third-party partners. LXRP has also expanded its process of improved and faster inhalation by the body of fat-soluble vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) in pain medications, and even nicotine, a good example of bioabsorption breakthrough technology (http://dtn.fm/ssLY4). LXRP is now positioned to license its technology to tobacco giants and major drug companies, as well as cannabinoid biopharmaceutical companies.

As a result, LXRP sees new business opportunities in 2018. The company is now positioned to out-license — at a high royalty rate — its intellectual property (IP) to biopharmaceutical companies as a partner rather than a competitor, working with other companies, including cannabinoid edible producers, instead of competing with them.

An R&D-driven company, LXRP is disrupting the global industry by specializing in the ingestion of edible forms of cannabinoids. Its technology and process platform offers more rapid forms of delivery and intestinal absorption of orally-taken cannabinoids, vitamins, nicotine and non-steroidal inflammatory drugs. Its patented process not only improves the body’s absorption of edible cannabinoids; it also masks taste, reduces by roughly 75% the time of onset, and increases bio-absorption by 5-10x. The company has secured patents related to its processing technology in the U.S. and Australia, and it has a portfolio of some 19 national/regional patent application filings in some 44 countries (http://dtn.fm/Y6ekx).

Primarily a B2B company, LXRP also makes for demonstration purposes branded consumer products under the ViPova™, Lexaria Energy Foods, and TurboCBD™ brands. It recently acquired the remaining 49% of its majority owned Poviva Tea LLC subsidiary (http://dtn.fm/G3vKs). It now owns 100% ownership interest, reaffirming its commitment to the ViPova product lines, as noted by the company in a recent news release.

Separately, in financial news, LXRP has extended the date of its warrants issued on January 19, 2017, to expire on January 19, 2019. The exercise price and the quantity of the warrants has not changed, it said in a 8K SEC filing. LXRP, in its corporate presentation, said that the next round of capital investment is expected to be in “plant to bloodstream” companies, such as itself.

For more information, visit the company’s website at www.LexariaBioscience.com

Let us hear your thoughts: Lexaria Bioscience Corp. Message Board

• TripWitz offers innovative services in the online travel market
• Free online help from specialist travel agents
• Travel services offered to more than 20,000 global destinations

In recent years, online travel agencies have become more impersonal and less user-friendly, offering endless permutations for flights, accommodation, activities and transportation that have turned vacation planning into a nightmare. Visitors to these sites are suffering from the frustration of information overload, and many do not have the time to wade through it all to plan their vacations. As a result, many travelers are turning to traditional travel agents to assist. The MMGY Global Portrait of American Travelers (http://dtn.fm/wBWZ5) reports that only 13 percent of travelers made their reservations on online travel agency sites in 2016, compared to 36 percent in 2015. MMGY Global also reported that 50 percent of millennials booked their vacations through a travel agent between 2014 and 2015. To address this, Cache Elite Inc. (OTC: ILUS) launched an online travel service, TripWitz, offering access to free assistance from live travel agents. Travelers are now able to combine the convenience of online travel booking with human interaction from travel experts to answer queries and help with vacation planning.

Cache Elite was founded in 2012 to service the luxury goods, fine cabinetry and design services markets. In September, 2017 the company launched TripWitz (http://dtn.fm/apA6A), a new online global travel portal that is revolutionizing the travel service market. TripWitz is filling a breach in the online travel service market by offering custom vacation planning by industry experts completely free. Its Certified Designation Specialists take the load off travelers by conducting all research, and presenting options that meet individual requirements and maximize return on travel budgets. Travelers can rest assured that all bases are covered and that there will be no hidden fees or nasty surprises on vacation.

TripWitz offers travelers a portal to access real-time information on tour packages, fares, accommodation and destination activities. In addition, they can enlist the help of travel agents at no charge to find deals at the best prices and to make reservations. TripWitz uses Google’s ITA Gateway software to connect to global airlines, which enables it to provide immediate data on fares, flight schedules and seat availability. The company is now accepting Bitcoin as payment mechanism for their travel services including airfare, hotel accommodation, transportation and excursions (http://dtn.fm/iN5JN).

TripWitz can offer travel services to over 20,000 destinations. It has established partnerships with more than 500,000 service providers including airlines, hotels, luxury villas, surface transportation and adventure activity companies. The company has made a concerted effort to sign up vacation partners in Hawaii and Bermuda to offer travelers exciting vacation packages as an alternative to destinations in many hurricane-ravaged parts of the Caribbean.

Through its subsidiary, TripWitz, Cache Inc. has reintroduced the human element to the online travel sector, worth multi-billions of dollars. In doing so, it is providing a much-needed service to ease the burden of vacation planning, ensuring customer preferences are met while maximizing vacation budgets.

For more information, visit the company’s website at www.TripWitz.com

Let us hear your thoughts: Cache Elite Inc. Message Board

• Helps lottery players social network with other players to form game pools
• Company expects to reach nearly half the United States by end of 2018
• Famed Star Trek, Priceline actor William Shatner acts as company spokesman

California residents playing the MEGA Million, Powerball and Super Lotto Plus lotteries may now find it easier than ever to team up with other lottery players in the hope of bettering their chances of winning, thanks to a publicly traded online service that brokers ticket purchases for customers who don’t want to wait in line themselves, or who may not know other players willing to pool their resources.

LottoGopher Holdings Inc. (OTCQB: LTTGF) (CSE: LOTO) (FRA: 2LG) is a messenger service that provides the in-person buyers for subscribing clients to what is essentially the company’s large “social network for playing the lottery.”

LottoGopher users have a range of options to choose from, whether playing the California lotteries as individuals with a single ticket or as public or private groups connected by a common desire to pool resources for a better chance at winning millions, or even billions, of dollars.

Last year, the Powerball jackpot reached $1.59 billion before winners in three states — including California — claimed a split of the prize. The Powerball was again poised to reach the $1 billion mark in August of this year before that was preempted by a $758.7 million winner in Massachusetts.

In California, where LottoGopher is offered exclusively at the present time, some 39 million residents spend about $6 billion each year on lotteries. And the company is laying the groundwork to enter the market in nearly two dozen other states by the end of 2018, including Texas.

A “key legal contractor” employed by the company is advising LottoGopher and helping it through the due diligence process for “Phase 1” of its launch in a number of states outside California, the company told Newsfile Corp. in September (http://dtn.fm/E7Eur).  “What we’ve done is take our model and apply it to the existing compliance structure within each state,” LottoGopher President, CEO and Director James Morel said during an interview with NetworkNewsWire in September (http://dtn.fm/qY4mD). “We’ve put executives in place who have experience in working at the lottery level. Between the game plan and the people we have to execute it, we hope by the end of 2018 to be in all 22 of those expansion states,” Morel said.

LottoGopher’s anticipated expansion to nearly half the nation creates the possibility of even larger network options for players who want to pool their resources with others to boost their odds.

For now, the company’s growth in California is enough to gain national attention. The same month that Morel’s interview was published, LottoGopher announced that actor William Shatner, known for his landmark role in the Star Trek franchise and other TV series as well as his humorous appearances as an advertising spokesman for discount travel site Priceline (NASDAQ: PCLN), has been signed as the spokesman for the lottery messaging service (http://dtn.fm/Hk5QS).

Approximately $2 billion in lottery prizes remain unclaimed each year, according to estimates reported by CNN last year (http://dtn.fm/GtOa6). LottoGopher’s resources provide forgetful users the ability to easily organize and keep track of their investments in a potentially life-changing state gaming system.

For more information, visit the company’s website at www.LottoGopher.com

Let us hear your thoughts: LottoGopher Holdings Inc. Message Board

• MCOA is building a role in cannabis and hemp industry through strategic network
• Growing legal cannabis markets estimated to reach $37.3 billion by 2024
• Hemp market estimates foresee growth into the billions by 2020

Amid the drive of several states to put the legal framework for recreational marijuana use into place, Marijuana Company of America, Inc. (OTC: MCOA) is building upon its vertically integrated business strategy by taking a unique approach to how companies within the industry position themselves in the marketplace.

On January 1, recreational marijuana use will become legal in California (http://dtn.fm/CzFD2), which will complete the regulatory picture for cannabis use on the West Coast, since Washington, Oregon and Alaska legalized the drug earlier this year. Those states join others across the country, including Colorado, Nevada, Massachusetts and Maine, where recreational use is allowed or will be allowed by next year. Canada is also expected to legalize recreational use next year.

That trend, in addition to the existing regulation of medicinal uses of marijuana extracts in most of the United States, is fueling a booming market that analysis portal Statista predicts may exceed $37.3 billion by 2024. While other estimates may be a bit more conservative, all agree that the demand for legalization is driving an industry with immense potential for profit.

Pursuant to an agreement signed earlier this year, Marijuana Company of America, Inc. and Bougainville Ventures are constructing and will deliver a turnkey state-of-the-art cultivation and processing facility in Oroville, Washington. The 30,000 sq. ft. greenhouse will house a tier-3 production and processing I-502 tenant with decades of experience in cannabis cultivation. Anticipated completion of funding for the project is expected in Q4 2017.

Analysts are also forecasting a boom in the hemp industry. Hemp Business Journal predicts that the sector will rise from $688 million in 2016 to a little over $2.2 billion by 2020 (http://dtn.fm/01QpT).

MCOA’s wholly own subsidiary, hempSMART, is developing all-natural formulations that include non-THC industrial hemp-based cannabinoids with distribution through a unique marketing and affiliate-based program. The founders of MCOA have developed the hempSMART model around the concept of building a global network of diverse and experienced affiliate marketers.

MCOA also signed a joint venture with Canadian public company Global Hemp Group, Inc. (CSE: GHG) (OTC: GBHPF) to conduct industrial hemp trials in New Brunswick, Canada. The companies have retained hemp producer Space Cowboys, Inc. (“SC”) as advisers on the trials. SC has extensive expertise in growing high cannabinoid (CBD & CBG) hemp for extraction and will assist GHG and MCOA in maximizing cannabinoid production as the group ramps up cultivation operations in New Brunswick in the coming years.

“We are at a crossroads of global legalization of our industry,” MCOA CEO Donald Steinberg stated in a news release (http://dtn.fm/mzeC5). “The world has a massive need for cannabis and hemp products and services. This process of countries shifting to a legal cannabis and hemp structure is something that will occur only once in the history of a country, and we are proud to be a frontrunner in the industry.”

For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com

Let us hear your thoughts: Marijuana Company of America, Inc. Message Board

• Launching its Chinese Daily Video News Broadcast from NYSE on cryptocurrency news in 1Q2018
• CIIX sets FY2018 goals of greater than 100% sales increase, reduced costs, and profitability
• Consilium Global Research projects CIIX to reach revenues of $14.8 million by FY2020 at a compounded annual growth rate (CAGR) of nearly 100%
• CIIX reports FY2017 YOY operating sales gain of 76%

ChineseInvestors.com, Inc. (OTCQB: CIIX) is a diverse company with goals set by Warren Wang, company founder and CEO, of a 100% gain in sales in FY2018 after achieving a 76% YOY increase in operating revenues in FY2017. The goal in FY2018 is not only the large sales gain, but a reduction in costs and profitability.

CIIX is targeting its goal of becoming the primary medical cannabis Chinese community oriented publicly-traded company. It has diverse offerings to the global Chinese-speaking population. These include financial education and market analysis, in addition to R&D and distribution of legalized, hemp-based cannabidiol (CBD). It now also offers Chinese Daily Video News Broadcast on cryptocurrencies and blockchain news from the NYSE, along with its line of CBD-infused skin care products.

At the same time, CIIX is generating subscription revenue and advertising sales. It also offers public relations and investor relations consulting services to Chinese companies.

Recently, it expanded its board by three individuals who have extensive financial and industry experience: Patrick Leung, Keevin Gillespie and Delray Wannemacher. The goal, according to CEO Wang, is to add to the company’s board individuals who can help grow the company’s Consumer Retail and Financial Services/Media divisions.

For more information, visit the company’s website at www.ChineseInvestors.com

Let us hear your thoughts: ChineseInvestors.com, Inc. Message Board

• Unique patented drug delivery platform
• Active in world’s largest beverage market
• Technology that compliments rather than competes with CBD companies

An old and popular beverage is being supplemented in a healthy, flavorful way now that Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is on the scene. Having increased its ownership stake in PoViva Tea, LLC from 51% to 100%, the innovative drug delivery biotech plans to apply its patented DehydraTECH™ technology to supplement a range of black teas with cannabidiol (CBD) from hemp. After water, tea is the most widely consumed beverage in the world and is an ideal adjuvant to speed adoption of CBD supplements. Now that it is complementing the recognized virtues of tea with the therapeutic benefits of CBD, Lexaria is poised to revolutionize the age-old ritual of afternoon tea.

America is a nation of tea drinkers. In 2016, Americans drank 84 billion cups of tea; that is 260 cups for every man, woman and child. Of the 3.8 billion gallons thus consumed, about 80% was black tea, 16% was green tea, while the rest was either Oolong, white or dark tea. Unlike the rest of the world, Americans like their tea cold. About 80 percent of the tea consumed on a daily basis is chilled. However, hot tea appears to be gaining in popularity with the health conscious. The Tea Association of the USA reports (http://dtn.fm/4lDBE) that ‘total category sales for hot tea have increased more than 15% over the last 5 years…’ The Association ‘anticipates strong, continuous growth, with a CAGR of 4-6% (coming) from all segments driven by variety, convenience, health benefits, sustainability, availability, continued innovation and the discovery of unique, flavorful and high-end specialty teas’.

Lexaria’s acquisition of Poviva Tea, LLC, announced on November 2 (http://dtn.fm/My4oq), gives Lexaria a toehold in this vast $7 billion plus market and consolidates ownership of Poviva Tea, LLC as a wholly owned Lexaria Bioscience subsidiary. The move also simplifies future operations and certain intellectual property ownership issues. In addition, Lexaria announced that, effectively immediately, PoViva Tea will now operate with the trade name of ViPova^TM Tea. The company believes that the rebranding will ensure long-term protection of intellectual rights. At the center of this strategy is Lexaria’s patented DehydraTECH technology, which is focused on the improving the delivery of many commonly used Active Pharmaceutical Ingredients (APIs). The DehydraTECH technology provides an additional layer of effectiveness, designed to harmonize with the intellectual property of third parties, which both patented and generic API substances can employ. Lexaria’s long term strategy is to partner with the world’s leading firms as they deliver best-of-class products to their existing large consumer groups.

Lexaria is constantly exploring ways to make the health benefits of cannabinoids (CBD) more accessible and the company’s DehydraTECH technology is a way to do so. Many hemp products on the market are simply mixtures of hemp oil with other ingredients. However, Lexaria’s patented methodology infuses organically sourced hemp oil into the molecules of other substances, such as lipids, which, as it turns out, form the basis of the human endocannabinoid system. Consequently, the body better absorbs products employing the technology.

Presently, Lexaria is the only company in the world that has been awarded a patent for the improved (oral or ingestible, including pills) delivery of all non-psychoactive cannabinoids. Patents have been awarded in the U.S. and Australia and are pending in 40 more countries. This puts the company in the unusually advantageous position of owning proprietary technology that can deliver a vast range of non-psychoactive cannabinoid-based drugs.

Lexaria is already applying its innovative delivery technology to the range of ViPova black teas, which come from the province of Yunnan in China and are supplemented with hemp oil infused within dried evaporated non-fat milk. Introduced in January 2015, the tea is available in a variety of varieties and flavors. The ViPova range runs from 8 to 32 bag portions and varieties include Decaf English Breakfast, Earl Grey, Herbal Bengal Chai, Herbal Cherry Black Tea, Herbal Masala Chai, Low-Caf Organic Evening Green Tea and ViPova Light.

For more information, visit the company’s website at www.LexariaEnergy.com

Let us hear your thoughts: Lexaria Bioscience Corp. Message Board